Patent · US Expired

4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]-ethenyl]-3(2H)- pyridazinones and related compounds

US4599332A · kind A · utility

8Cited by
2References
12Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 9, 1984
Grant dateJul 8, 1986
Priority date
Expiry dateNov 9, 2004

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

4,5-Dihydro-6-[2-[4-(1H -imidazol-1-yl)phenyl]alkylenyl or alkylene-3(2H)-pyridazinones and related compounds and pharmaceutically acceptable acid addition salts thereof are useful as cardiotonic and antihypertensive agents. The above compounds cause a significant increase in myocardial contractility in the dog and also cause a decrease in blood pressure in the spontaneously hypertensive rat. The compounds are produced by reacting the appropriate .gamma.-oxobutanoic acid with a suitably substituted hydrazine to provide 4,5-dihydro-6-[4-[imidazolylphenyl]-alkenylene or alkylene-3(2H)-pyridazinones which may be oxidized to 6-[4-[imidazolylphenyl]alkenylene or alkylene-3(2H)-pyridazinones.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.